leisure time -WSS

leisure time

author：knowledge 2025-09-29 22:49:46 - browse：9232

How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Virginia high school admissions case could be legal follow
Next article： STAT Summit: GSK CEO on pharma giant's new direction

hotspot

entertainment

WSS

Novo: Oral version of Ozempic leads to 15% weight loss

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

UnitedHealth’s board chair also owns a personal investment firm

Beam Therapeutics to lay off 20% of its staff, re

Mom launches Girl Scout troop for LGBTQ youth in Texas

HHS leader on health, climate change and biopharma emissions

hotspot

leisure time

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Reanimated hearts work just as well for transplants, study finds

State Dept. review finds Biden bears some blame for Afghanistan failures

Why health workers in Gaza are injured or die at high rates

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Summit: How a Chicago ER doctor tackles gun violence

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The thinking behind the controversial eating disorder chatbot Tessa

Affirmative action in medical school literally saved lives

CEOs share strategies for surviving biotech slump

leisure time

Inside the rise of 'mukbang' eating videos

STAT Summit: How a Chicago ER doctor tackles gun violence

Hospital price transparency does save money, advocate argues

Pharmacists can make shortage drugs, but at what cost?

Solve the antibiotic resistance crisis with preventive drugs

Can medical device makers keep up in the race to treat obesity?

hotspot

leisure time

entertainment

focus